Concepedia

Anthony Sanfiz

AS

8

Publications

498

Citations

8

H-Index

2001

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Rockefeller University

Anthony Sanfiz is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in medicine, biochemistry, and natural sciences.

Top concepts

Publications per year

2001–2019

8

Publications

8

Regulation of PTEN binding to MAGI-2 by two putative phosphorylation sites at threonine 382 and 383.

Tatyana Tolkacheva, M Boddapati, Anthony Sanfiz et al. · PubMed · 2001 · 149 citations

, , +17

Tyrosine sulfation of CCR5 N-terminal peptide by tyrosylprotein sulfotransferases 1 and 2 follows a discrete pattern and temporal sequence

Christoph Seibert, Martine Cadène, Anthony Sanfiz et al. · Proceedings of the National Academy of Sciences · 2002 · 107 citations · Full text

Discovery of Vibegron: A Potent and Selective β<sub>3</sub>Adrenergic Receptor Agonist for the Treatment of Overactive Bladder

Scott D. Edmondson, Cheng Zhu, Nam Fung Kar et al. · Journal of Medicinal Chemistry · 2015 · 101 citations · Full text

Pharmacological Characterization of a Novel Beta 3 Adrenergic Agonist, Vibegron: Evaluation of Antimuscarinic Receptor Selectivity for Combination Therapy for Overactive Bladder

Jerry Di Salvo, Hiroshi Nagabukuro, L. Alexandra Wickham et al. · Journal of Pharmacology and Experimental Therapeutics · 2016 · 58 citations

Development and validation of an in vitro 3D model of NASH with severe fibrotic phenotype.

Sumanta Mukherjee, Leonid Zhelnin, Anthony Sanfiz et al. · PubMed · 2019 · 38 citations · Full text

Rows per page

1–5 of 8